![](https://investorshub.advfn.com/uicon/25583.png?cb=1468325215)
Saturday, July 12, 2014 12:59:32 PM
Insider Transactions Reported - Last Two Years
Date Insider Shares Type Transaction Value*
Jun 20, 2011 DIWAN ANIL
Officer 11,000 Direct Sale at $1.35 - $1.36 per share. 15,0002
Jun 17, 2011 DIWAN ANIL
Officer 5,000 Direct Sale at $1.37 per share. 6,850
Jun 16, 2011 DIWAN ANIL
Officer 13,000 Direct Disposition (Non Open Market) at $1.38 per share. 17,940
Jun 15, 2011 DIWAN ANIL
Officer 11,100 Direct Disposition (Non Open Market) at $1.38 per share. 15,317
Feb 15, 2011 DIWAN ANIL
Officer 2,117,800 Direct Disposition (Non Open Market) at $0 per share. N/A
Nov 12, 2010 SEYMOUR EUGENE
Director 2,500,000 Direct Disposition (Non Open Market) at $0 per share. N/A
Jun 24, 2010 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 353,982 Direct Sale at $0.57 per share. 201,769
Dec 3, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 5,000 Direct Automatic Sale at $0.85 per share. 4,250
Dec 2, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 15,000 Direct Automatic Sale at $0.88 per share. 13,200
Dec 1, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 15,000 Direct Automatic Sale at $0.84 per share. 12,600
Nov 30, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 20,000 Direct Automatic Sale at $0.85 per share. 17,000
Nov 25, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 34,000 Direct Automatic Sale at $0.89 per share. 30,260
Nov 24, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 30,045 Direct Automatic Sale at $0.84 per share. 25,237
Nov 23, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 10,000 Direct Automatic Sale at $0.93 per share. 9,300
Nov 20, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 42,500 Direct Automatic Sale at $0.89 per share. 37,825
Nov 19, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 40,000 Direct Automatic Sale at $0.89 per share. 35,600
Nov 18, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 10,000 Direct Automatic Sale at $0.88 per share. 8,800
Nov 17, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 10,000 Direct Automatic Sale at $0.88 per share. 8,800
Nov 16, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 30,000 Direct Automatic Sale at $0.87 per share. 26,100
Nov 13, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 10,000 Direct Automatic Sale at $0.86 per share. 8,600
Nov 12, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 20,000 Direct Automatic Sale at $0.86 per share. 17,200
Nov 11, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 20,000 Direct Automatic Sale at $0.85 per share. 17,000
Nov 10, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 20,000 Direct Automatic Sale at $0.82 per share. 16,400
Nov 6, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 20,000 Direct Automatic Sale at $0.82 per share. 16,400
Nov 5, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 10,000 Direct Automatic Sale at $0.82 per share. 8,200
Nov 5, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 25,000 Direct Automatic Sale at $0.83 per share. 20,750
Nov 2, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 10,000 Direct Automatic Sale at $0.84 per share. 8,400
Oct 30, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 30,000 Direct Automatic Sale at $0.86 per share. 25,800
Oct 29, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 10,000 Direct Automatic Sale at $0.89 per share. 8,900
Oct 28, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 49,000 Direct Automatic Sale at $0.85 per share. 41,650
Oct 22, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 10,000 Direct Automatic Sale at $0.59 per share. 5,900
Oct 21, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 10,000 Direct Automatic Sale at $0.60 per share. 6,000
Oct 15, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 20,000 Direct Automatic Sale at $0.75 per share. 15,000
Oct 13, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 10,000 Direct Automatic Sale at $0.77 per share. 7,700
Sep 30, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 10,000 Direct Automatic Sale at $0.81 per share. 8,100
Sep 29, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 30,000 Direct Automatic Sale at $0.81 per share. 24,300
Sep 28, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 20,000 Direct Automatic Sale at $0.85 per share. 17,000
Sep 25, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 17,500 Direct Automatic Sale at $0.88 per share. 15,400
Sep 24, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 20,000 Direct Automatic Sale at $0.86 per share. 17,200
Sep 23, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 10,000 Direct Automatic Sale at $0.86 per share. 8,600
Sep 21, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 20,000 Direct Automatic Sale at $0.90 per share. 18,000
Sep 18, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 20,000 Direct Automatic Sale at $0.90 per share. 18,000
Sep 16, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 17,900 Direct Automatic Sale at $0.91 per share. 16,289
Sep 15, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 20,000 Direct Automatic Sale at $0.95 per share. 19,000
Sep 14, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 20,000 Direct Automatic Sale at $0.97 per share. 19,400
Sep 10, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 30,000 Direct Automatic Sale at $0.95 per share. 28,500
Sep 9, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 30,000 Direct Automatic Sale at $0.90 per share. 27,000
Sep 8, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 20,000 Direct Automatic Sale at $0.89 per share. 17,800
Sep 4, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 20,000 Direct Automatic Sale at $0.84 per share. 16,800
Sep 3, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 20,000 Direct Automatic Sale at $0.85 per share. 17,000
Sep 1, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 10,000 Direct Automatic Sale at $0.88 per share. 8,800
Aug 25, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 10,000 Direct Automatic Sale at $0.91 per share. 9,100
Aug 24, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 12,000 Direct Automatic Sale at $0.86 per share. 10,320
Aug 14, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 10,000 Direct Automatic Sale at $0.87 per share. 8,700
Aug 12, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 20,000 Direct Automatic Sale at $0.96 per share. 19,200
Aug 11, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 30,000 Direct Automatic Sale at $0.95 per share. 28,500
Aug 10, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 30,000 Direct Automatic Sale at $0.84 per share. 25,200
Aug 6, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 20,000 Direct Automatic Sale at $0.74 per share. 14,800
Aug 5, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 1,000 Direct Automatic Sale at $0.75 per share. 750
Aug 4, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 10,000 Direct Automatic Sale at $0.75 per share. 7,500
Aug 3, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 10,000 Direct Automatic Sale at $0.74 per share. 7,400
Jul 31, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 20,000 Direct Automatic Sale at $0.73 per share. 14,600
Jul 30, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 20,000 Direct Automatic Sale at $0.74 per share. 14,800
Jul 29, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 20,000 Direct Automatic Sale at $0.73 per share. 14,600
Jul 28, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 19,500 Direct Automatic Sale at $0.74 per share. 14,430
Jul 27, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 12,000 Direct Automatic Sale at $0.74 per share. 8,880
Jul 23, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 10,000 Direct Automatic Sale at $0.63 per share. 6,300
Jul 16, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 10,000 Direct Automatic Sale at $0.65 per share. 6,500
Jul 15, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 4,100 Direct Automatic Sale at $0.68 per share. 2,788
Jul 14, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 49,800 Direct Automatic Sale at $0.65 per share. 32,370
Jul 13, 2009 THERACOUR PHARMA, INC.
Beneficial Owner (10% or more) 200 Direct Automatic Sale at $0.63 per share. 126
The SwingTrade Portfolio is up 28.3% YTD, 83.5% in 2013, and 475.5% since inception.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=102716798
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM